Roth Capital Comments on Itron’s Q1 Earnings (NASDAQ:ITRI)

Itron, Inc. (NASDAQ:ITRI) – Equities research analysts at Roth Capital lifted their Q1 2025 EPS estimates for shares of Itron in a research note issued on Tuesday, February 25th. Roth Capital analyst C. Moore now expects that the scientific and technical instruments company will earn $1.26 per share for the quarter, up from their previous estimate of $1.09. The consensus estimate for Itron’s current full-year earnings is $5.33 per share. Roth Capital also issued estimates for Itron’s Q2 2025 earnings at $1.18 EPS, Q3 2025 earnings at $1.36 EPS, Q4 2025 earnings at $1.41 EPS, FY2025 earnings at $5.20 EPS and FY2026 earnings at $5.64 EPS.

ITRI has been the subject of several other research reports. Canaccord Genuity Group raised their price objective on shares of Itron from $130.00 to $132.00 and gave the stock a “buy” rating in a report on Wednesday. Piper Sandler raised their price target on Itron from $110.00 to $119.00 and gave the company a “neutral” rating in a report on Friday, November 1st. Roth Mkm boosted their price objective on Itron from $125.00 to $130.00 and gave the stock a “buy” rating in a research note on Friday, November 1st. StockNews.com upgraded Itron from a “buy” rating to a “strong-buy” rating in a research note on Friday, February 21st. Finally, Robert W. Baird lifted their price target on Itron from $123.00 to $132.00 and gave the company an “outperform” rating in a report on Friday, November 1st. Three investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Itron presently has an average rating of “Moderate Buy” and a consensus price target of $125.50.

Itron Trading Up 5.8 %

Shares of ITRI stock opened at $107.72 on Thursday. The company has a market capitalization of $4.86 billion, a P/E ratio of 22.07, a P/E/G ratio of 0.81 and a beta of 1.46. Itron has a 12-month low of $86.13 and a 12-month high of $124.90. The company has a quick ratio of 2.83, a current ratio of 3.36 and a debt-to-equity ratio of 0.91. The firm has a 50-day moving average price of $104.98 and a 200 day moving average price of $106.85.

Insider Buying and Selling

In other Itron news, CFO Joan S. Hooper sold 2,322 shares of the company’s stock in a transaction on Monday, February 24th. The shares were sold at an average price of $92.90, for a total transaction of $215,713.80. Following the completion of the sale, the chief financial officer now owns 92,076 shares in the company, valued at approximately $8,553,860.40. The trade was a 2.46 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CAO David Marshall Wright sold 317 shares of the stock in a transaction on Monday, February 24th. The shares were sold at an average price of $92.90, for a total value of $29,449.30. Following the completion of the transaction, the chief accounting officer now directly owns 8,108 shares in the company, valued at approximately $753,233.20. This trade represents a 3.76 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 3,287 shares of company stock worth $305,362 over the last three months. 1.45% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Itron

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ITRI. Virtue Capital Management LLC boosted its holdings in Itron by 5.4% during the fourth quarter. Virtue Capital Management LLC now owns 8,249 shares of the scientific and technical instruments company’s stock worth $896,000 after buying an additional 419 shares during the last quarter. GTS Securities LLC bought a new position in Itron during the 4th quarter worth approximately $288,000. Vise Technologies Inc. boosted its stake in Itron by 18.4% during the 4th quarter. Vise Technologies Inc. now owns 2,456 shares of the scientific and technical instruments company’s stock worth $267,000 after acquiring an additional 381 shares during the last quarter. Squarepoint Ops LLC grew its holdings in Itron by 52.6% during the fourth quarter. Squarepoint Ops LLC now owns 139,538 shares of the scientific and technical instruments company’s stock valued at $15,151,000 after purchasing an additional 48,084 shares during the period. Finally, Tema Etfs LLC bought a new stake in Itron in the fourth quarter valued at approximately $517,000. Institutional investors own 96.19% of the company’s stock.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.